Craig Mayer, Nick WIlliams, Vojtech Huser
Lister Hill National Center for Biomedical Communications, National Library of Medicine, NIH, Bethesda, MD

See the full regCTG repository at https://github.com/lhncbc/CRI/tree/master/regCTG

To return to the list of conditions and view other reports go to https://lhncbc.github.io/CRI/regCTG/regCTG-condition_report_links.html


Study Counts

Type Study_count
Total_Studies 1671
interventional 1469
Observational 175
Registry 27

Studies over Time by Start Date

```

Interventional Trials

Intervention Type

intervention_type Study_Count
Drug 602
Drug|Other 111
Drug|Radiation 68
Biological|Drug 64
Procedure 51
Biological 47
Drug|Procedure 47
Biological|Drug|Other 40
Device 39
Drug|placebo 39
Radiation 38
Drug|Other|Radiation 31
Other 27
Drug|Procedure|Radiation 21
Drug|Other|Procedure 18
Biological|Other 15
Device|Drug 13
Drug|Other|placebo 11
Biological|Drug|Procedure 10
Biological|Drug|Radiation 10
Drug|Other|Procedure|Radiation 10
Other|Radiation 10
Diagnostic Test 9
Other|Procedure 8
Biological|Drug|Other|placebo 7
Other|Procedure|Radiation 7
Biological|Drug|placebo 6
Biological|Drug|Procedure|Radiation 6
Biological|Drug|Other|Procedure 5
Biological|Drug|Other|Procedure|Radiation 5
Behavioral 4
Biological|Other|Radiation 4
Combination Product 4
Dietary Supplement 4
Behavioral|Other 3
Biological|Other|Procedure 3
Biological|Procedure 3
Device|Procedure 3
Dietary Supplement|Drug 3
Drug|Genetic 3
Drug|Genetic|Other 3
Drug|Other|placebo|Procedure 3
Drug|placebo|Radiation 3
Genetic 3
Procedure|Radiation 3
Behavioral|Dietary Supplement|Other 2
Behavioral|Radiation 2
Biological|Drug|Other|Radiation 2
Biological|Other|placebo 2
Combination Product|Drug 2
Device|Drug|Other 2
Device|Drug|Procedure 2
Diagnostic Test|Drug 2
Dietary Supplement|Drug|Other 2
Drug|Genetic|Other|Procedure 2
Behavioral|Device|Other|Procedure|Radiation 1
Behavioral|Other|Procedure 1
Behavioral|Procedure 1
Biological|Combination Product 1
Biological|Device|Drug|Other 1
Biological|Drug|Genetic|Other 1
Biological|Drug|placebo|Radiation 1
Biological|Other|Procedure|Radiation 1
Biological|placebo 1
Biological|Radiation 1
Combination Product|Other 1
Combination Product|Other|Procedure 1
Device|Diagnostic Test 1
Device|Drug|Radiation 1
Device|Other 1
Device|Other|Procedure|Radiation 1
Device|Procedure|Radiation 1
Dietary Supplement|Drug|Other|placebo|Procedure 1
Dietary Supplement|Drug|Other|placebo|Radiation 1
Dietary Supplement|Other|placebo 1
Dietary Supplement|Other|placebo|Procedure 1
Dietary Supplement|placebo 1
Drug|Genetic|Other|Procedure|Radiation 1
Drug|Other|placebo|Radiation 1
Genetic|placebo 1

Count of Studies by Intervention (normalized and mapped)

Interventions over Time

Yearly studies for each intervention by start date

Studies by Country

Country Study_Count
United States 843
China 86
France 54
Korea, Republic of 40
Germany 38
Canada 32
United Kingdom 25
United States|Canada 25
NA 22
Italy 16
Spain 15
United States|Puerto Rico 8
Japan 7
Denmark 6
Belgium 5
Brazil 5
Netherlands 5
Russian Federation 5
Switzerland 5
Taiwan 5
United States|Spain 5
Turkey 4
United States|Canada|Korea, Republic of 4
United States|Japan 4
United States|United Kingdom 4
Australia 3
Cuba 3
Egypt 3
India 3
Israel 3
Singapore 3
Sweden 3
United States|Canada|Japan|Korea, Republic of 3
United States|Germany 3
United States|Korea, Republic of 3
Australia|New Zealand 2
Belgium|Netherlands 2
Hong Kong 2
Iran, Islamic Republic of 2
Japan|Korea, Republic of|Taiwan 2
Norway 2
Poland 2
Portugal 2
United States|Canada|Israel 2
United States|Canada|Puerto Rico 2
United States|Canada|Switzerland 2
United States|France 2
United States|France|Germany 2
United States|Israel 2
United States|Japan|Korea, Republic of 2
United States|Mexico 2
United States|Netherlands 2
Argentina 1
Australia|Belgium|Germany|Netherlands|Switzerland|United Kingdom 1
Australia|Canada|China|France|Germany|Hong Kong|Ireland|Korea, Republic of|Norway|Singapore|Spain|Sweden|Taiwan|United Kingdom 1
Austria|Belgium|Denmark|Germany|Lithuania|Netherlands|Norway|Spain|Sweden 1
Austria|Belgium|Netherlands 1
Austria|France|Germany|Hungary|Switzerland 1
Austria|Germany|Spain|United Kingdom 1
Belarus|Hungary|Poland|Russian Federation|Ukraine 1
Belgium|Canada|France 1
Belgium|France|Germany|Hungary|Netherlands|Poland|United Kingdom 1
Belgium|France|Germany|Italy|Poland|Spain 1
Belgium|France|Netherlands|Switzerland 1
Belgium|Norway 1
Belgium|United Kingdom 1
Bosnia and Herzegovina|Croatia|Korea, Republic of|Spain|Taiwan|United Kingdom 1
Brazil|Canada|Cyprus|United Kingdom 1
Canada|France 1
China|Korea, Republic of|Malaysia|Taiwan 1
China|Korea, Republic of|Thailand 1
China|Malaysia|Philippines|Thailand 1
China|United States|Argentina|Austria|Canada|Croatia|Greece|Ireland|Japan|Korea, Republic of|Malaysia|Netherlands|Portugal|Romania|Spain|Taiwan|Thailand|Turkey|United Kingdom 1
Czech Republic|Hungary|Ukraine 1
Czechia 1
Denmark|France|Ireland|United Kingdom 1
Denmark|France|Sweden|United Kingdom 1
Denmark|Netherlands|United Kingdom 1
Finland|Sweden 1
France|Germany 1
France|Martinique 1
France|Spain 1
Georgia|Hong Kong|India|Moldova, Republic of|Serbia|Taiwan|Thailand|Ukraine 1
Germany|Latvia 1
Germany|Netherlands 1
Germany|Spain|Switzerland 1
Germany|Switzerland 1
Greece 1
Hong Kong|United States|Belgium|Brazil|Czech Republic|Egypt|France|Germany|Hungary|Italy|Korea, Republic of|Netherlands|Russian Federation|Singapore|South Africa|Spain|Switzerland|Taiwan|Thailand|Turkey|United Kingdom 1
Japan|Korea, Republic of 1
Japan|United States|Australia|Belgium|Brazil|Canada|Chile|China|Colombia|France|Germany|Israel|Italy|Korea, Republic of|Mexico|Peru|Poland|Spain|Taiwan|United Kingdom 1
Jordan|Lebanon 1
Latvia|Turkey|Hungary 1
Lithuania 1
Norway|Sweden 1
Poland|Ukraine 1
Romania|United States|Australia|Brazil|Canada|France|Germany|Hungary|Italy|Japan|Korea, Republic of|Russian Federation|Spain|Taiwan|Thailand|Turkey|United Kingdom 1
Russian Federation|Bulgaria|Czechia|Germany|Latvia|Ukraine 1
Saudi Arabia 1
Spain|Czechia|France|Germany|Israel|Italy|Norway|Poland|Portugal|United Kingdom 1
Spain|United Kingdom 1
United States|Argentina|Australia|Austria|Belgium|Brazil|Bulgaria|Chile|Estonia|France|Germany|Hungary|Israel|Italy|Japan|Korea, Republic of|Lithuania|Mexico|Poland|Portugal|Romania|Russian Federation|Singapore|Spain|Taiwan|United Kingdom 1
United States|Argentina|Australia|Austria|Belgium|Brazil|Canada|Chile|France|Germany|Hong Kong|Hungary|Ireland|Italy|Japan|Korea, Republic of|Malaysia|Peru|Philippines|Romania|Russian Federation|Taiwan|Thailand|Ukraine|United Kingdom 1
United States|Argentina|Australia|Belgium|Brazil|Canada|France|Germany|Italy|Netherlands|Norway|Russian Federation|Sweden|Ukraine|United Kingdom 1
United States|Argentina|Australia|Bosnia and Herzegovina|Brazil|Canada|Chile|Colombia|Croatia|Czechia|Egypt|Guatemala|India|Indonesia|Italy|Korea, Republic of|Lebanon|Malta|Mexico|New Zealand|Philippines|Poland|Romania|Russian Federation|South Africa|Spain|Taiwan|Thailand|Turkey|United Kingdom 1
United States|Argentina|Australia|France|Hungary|New Zealand|Poland|Romania|Russian Federation|Slovakia|Turkey|United Kingdom 1
United States|Argentina|Belgium|Canada|Czechia|Denmark|Finland|France|Germany|Hungary|Israel|Italy|Japan|Mexico|Netherlands|Poland|Puerto Rico|Russian Federation|Spain|United Kingdom 1
United States|Argentina|Belgium|Canada|France|Germany|Netherlands|Poland|United Kingdom 1
United States|Australia 1
United States|Australia|Austria|Belgium|Canada|China|Czechia|France|Germany|Italy|Japan|Korea, Republic of|Netherlands|Poland|Portugal|Russian Federation|Singapore|Spain|Taiwan|Ukraine 1
United States|Australia|Austria|Belgium|Canada|France|Germany|Italy|Russian Federation|Spain|Ukraine 1
United States|Australia|Belgium|Brazil|Canada|Czech Republic|Greece|Korea, Republic of|New Zealand|Poland|Portugal|Romania|Russian Federation|Spain 1
United States|Australia|Belgium|Brazil|Czechia|France|Germany|Hungary|Italy|Spain 1
United States|Australia|Belgium|Canada|France|Germany|Israel|Italy|Korea, Republic of|Netherlands|Spain|United Kingdom 1
United States|Australia|Belgium|Canada|Germany|Italy|Spain|United Kingdom 1
United States|Australia|Belgium|Canada|Hong Kong|Italy|Korea, Republic of|Poland|Russian Federation|Spain|United Kingdom 1
United States|Australia|Belgium|Canada|Spain|United Kingdom 1
United States|Australia|Belgium|Chile|Colombia|Czechia|France|Germany|Hungary|Italy|Peru|Poland|Romania|Spain|Turkey|United Kingdom 1
United States|Australia|Belgium|Czechia|France|Germany|Italy|Korea, Republic of|Poland|Spain 1
United States|Australia|Belgium|France|Hungary|Italy|Poland|Spain|United Kingdom 1
United States|Australia|Belgium|France|Israel|Spain|Taiwan|United Kingdom 1
United States|Australia|Brazil|Canada|Chile|China|Colombia|France|Guatemala|Hong Kong|Ireland|Israel|Japan|Korea, Republic of|Mexico|New Zealand|Peru|Poland|Russian Federation|South Africa|Spain|Switzerland|Taiwan|Turkey|Ukraine|United Kingdom 1
United States|Australia|Brazil|Chile|China|France|Germany|Guatemala|Ireland|Israel|Italy|Japan|Korea, Republic of|New Zealand|Poland|Russian Federation|Spain|Turkey|Ukraine|United Kingdom 1
United States|Australia|Canada|Germany|Italy|Poland|Russian Federation|Spain 1
United States|Australia|Canada|Ireland|New Zealand|Peru|Puerto Rico|United Kingdom 1
United States|Australia|Canada|Japan|Singapore|Spain|United Kingdom 1
United States|Australia|China|Japan 1
United States|Australia|France|Ireland|Italy|Japan|Korea, Republic of|Spain|Taiwan 1
United States|Australia|France|Japan 1
United States|Australia|Korea, Republic of|Taiwan 1
United States|Australia|New Zealand|Poland|Thailand 1
United States|Australia|Norway|Spain 1
United States|Australia|Singapore 1
United States|Australia|Spain 1
United States|Austria|Canada|Czechia|France|Hungary|Israel|Italy|Poland|Spain|Switzerland 1
United States|Belgium 1
United States|Belgium|Brazil|Canada|Chile|France|Germany|Israel|Italy|Japan|Korea, Republic of|Malaysia|Poland|Russian Federation|Singapore|Taiwan|Ukraine|United Kingdom 1
United States|Belgium|Canada|Czechia|Germany|Greece|Italy|Spain|Sweden|Turkey|Ukraine 1
United States|Belgium|Canada|France|Israel|Italy|Singapore|Spain|Taiwan 1
United States|Belgium|Canada|Israel 1
United States|Belgium|Canada|Spain 1
United States|Belgium|China|France|Germany|Hong Kong|Italy|Korea, Republic of|Netherlands|Singapore|Spain|Taiwan|United Kingdom 1
United States|Belgium|France|Germany|Italy|Korea, Republic of|Spain|United Kingdom 1
United States|Belgium|Italy 1
United States|Belgium|Italy|Spain|United Kingdom 1
United States|Belgium|Korea, Republic of|Netherlands|Poland 1
United States|Belgium|United Kingdom 1
United States|Bulgaria|Poland|Romania|Russian Federation|Ukraine 1
United States|Canada|France 1
United States|Canada|France|Germany|Hungary|Spain 1
United States|Canada|France|Germany|Mexico|Poland|Russian Federation 1
United States|Canada|France|Netherlands 1
United States|Canada|France|Netherlands|United Kingdom 1
United States|Canada|Germany|Korea, Republic of|Netherlands|Spain 1
United States|Canada|Hong Kong 1
United States|Canada|Ireland|Switzerland 1
United States|Canada|Japan|Korea, Republic of|Puerto Rico 1
United States|Canada|Japan|Korea, Republic of|Singapore|Taiwan 1
United States|Canada|Peru|Puerto Rico|South Africa 1
United States|Canada|Peru|South Africa 1
United States|Canada|Singapore 1
United States|Chile|China|Denmark|Estonia|France|Hong Kong|Hungary|Italy|Korea, Republic of|Russian Federation|Taiwan|Turkey 1
United States|China|France|Italy|Japan|Korea, Republic of|Poland|Puerto Rico|Romania|Russian Federation|Spain|Taiwan|Turkey|United Kingdom 1
United States|Czech Republic|France|Poland|Spain|United Kingdom 1
United States|Denmark|France|Spain 1
United States|Finland|Netherlands|Sweden|United Kingdom 1
United States|France|Germany|Hong Kong|Italy|Japan|Korea, Republic of|Poland|Russian Federation|Singapore|Spain|Taiwan 1
United States|France|Germany|Israel|Italy|Korea, Republic of|Spain|Taiwan 1
United States|France|Germany|Italy|Japan|Korea, Republic of|Poland|Romania|Russian Federation|Taiwan|Ukraine|United Kingdom 1
United States|France|Germany|Japan|Spain|United Kingdom 1
United States|France|Germany|Korea, Republic of|Netherlands|Spain|Taiwan|United Kingdom 1
United States|France|Hungary|Israel|Korea, Republic of|Romania|Russian Federation|Taiwan 1
United States|France|Israel|Korea, Republic of 1
United States|France|Italy|Korea, Republic of|Taiwan 1
United States|France|United Kingdom 1
United States|Germany|Korea, Republic of|Netherlands|Spain|Taiwan|United Kingdom 1
United States|Germany|Korea, Republic of|Spain 1
United States|Hong Kong|Japan|Korea, Republic of|Taiwan 1
United States|Hong Kong|Japan|Singapore|Taiwan 1
United States|Hungary|India|Russian Federation|Ukraine 1
United States|Israel|Korea, Republic of|Spain 1
United States|Italy 1
United States|Korea, Republic of|Spain|United Kingdom 1
United States|Netherlands|Peru 1
United States|Norway|Spain|United Kingdom 1
United States|Peru|South Africa 1
United States|Russian Federation 1
United States|South Africa 1
Vietnam 1

Sites per Study

Site_count Study_Count
1 773
2 131
3 76
4 41
5 37
6 30
7 31
8 17
9 19
10 12
11 10
12 7
13 9
14 14
15 8
16 10
17 5
18 7
19 4
20 9
21 6
22 7
23 9
24 4
25 6
26 4
27 2
28 6
29 4
30 5
31 3
32 2
33 3
34 3
35 4
36 5
37 1
39 3
41 2
42 1
43 4
44 2
45 1
46 3
47 1
48 1
49 1
50 1
52 2
54 1
55 2
56 1
57 2
58 1
59 3
61 1
62 3
63 1
66 1
68 1
72 1
73 2
75 1
78 2
79 1
81 1
86 2
87 2
93 1
95 2
96 1
97 1
101 1
103 1
106 1
107 1
108 1
113 1
115 1
116 1
133 1
134 1
135 1
140 2
141 1
145 1
147 1
154 1
155 1
157 2
161 1
162 1
163 1
167 2
168 1
170 1
180 1
182 1
186 1
187 2
193 1
196 1
200 1
221 1
224 1
227 1
233 2
234 1
235 1
241 1
255 1
267 1
280 1
283 1
315 1
337 1
358 1
364 1
367 1
395 1
410 1
433 1
439 1
480 1
504 1
508 3
534 1
539 1
540 1
549 1
573 1
632 1
634 1
640 1
663 1
670 1
672 1
687 1
699 1
709 1
718 1
756 1
789 1
798 1
807 1
849 1
894 1
896 1
931 1
936 1
938 1
1230 1
1296 1
1498 1

Phase

Phase Study_Count
Phase 2 661
Phase 1 265
N/A 177
Phase 3 155
Phase 1/Phase 2 151
Phase 2/Phase 3 25
Early Phase 1 22
Phase 4 13

Number of Arms

Number_of_Arms Count_of_Studies
1 766
2 464
3 88
4 50
5 8
6 13
7 7
9 4
10 2
11 2
13 1
14 1
15 1
NA 62

Enrollment Metrics by Phase

Measure Early.Phase.1 N.A Phase.1 Phase.1.Phase.2 Phase.2 Phase.2.Phase.3 Phase.3 Phase.4
Min. 8.00000 2.0000 1.00000 2.00000 1.00000 42.0000 5.0000 3.0000
1st Qu. 13.25000 25.0000 18.00000 34.50000 30.00000 123.7500 297.2500 40.0000
Median 19.50000 67.0000 28.50000 60.00000 50.00000 258.0000 496.0000 86.0000
Mean 21.09091 235.3559 43.21591 90.76159 82.29726 337.4583 728.8312 232.4615
3rd Qu. 30.00000 150.0000 45.00000 116.00000 90.00000 472.0000 765.2500 143.0000
Max. 37.00000 8300.0000 474.00000 527.00000 1400.00000 1408.0000 10273.0000 1030.0000

Trial Group Type

group_type Group_Count
Experimental 1919
Active Comparator 347
Other 78
NA 62
Placebo Comparator 60
No Intervention 39
Sham Comparator 2

Intervention Model

intervention_model Study_Count
Single Group Assignment 828
Parallel Assignment 550
Sequential Assignment 48
Crossover Assignment 21
NA 17
Factorial Assignment 5

Primary Purpose

primary_purpose Study_Count
Treatment 1308
Diagnostic 81
Prevention 24
Supportive Care 15
Other 14
Health Services Research 10
Screening 7
Basic Science 5
NA 4
Device Feasibility 1

Observational Studies

Studies by Country

Country Study_Count
United States 59
France 17
Italy 11
NA 11
United Kingdom 11
China 10
Canada 6
Belgium 5
Netherlands 4
Ireland 3
Korea, Republic of 3
Taiwan 3
Greece 2
Morocco 2
Spain 2
Algeria|Morocco 1
Belgium|Denmark|France|Germany|Italy|Netherlands|Norway|Romania|Spain|United Kingdom 1
Denmark 1
Denmark|France|Germany|Italy|Norway|Romania|Spain|United Kingdom 1
France|Belgium 1
Germany 1
Germany|Serbia|United Kingdom 1
Hungary 1
Kazakhstan 1
Norway 1
Pakistan 1
Russian Federation 1
Serbia 1
Spain|France|Germany|Italy|Japan|Netherlands|Sweden|United Kingdom 1
Switzerland 1
Thailand 1
Turkey 1
United States|Australia|Canada 1
United States|Canada|Germany 1
United States|Canada|Hong Kong 1
United States|Canada|Spain|Sweden|United Kingdom 1
United States|Israel 1
United States|Netherlands 1
United States|Netherlands|United Kingdom 1
United States|Puerto Rico 1
United States|Switzerland 1

Sites per Study

Site_count Study_Count
1 119
2 9
3 6
4 6
5 3
6 1
7 4
8 2
9 3
10 3
12 2
13 1
14 2
16 3
17 1
18 2
19 1
22 1
36 1
57 1
66 1
101 1
143 1
187 1

Enrollment Metrics

Measure Observational
Min 3.000
1st Qu 58.500
Median 156.500
Mean 4982.328
3rd Qu 500.000
Max 684815.000

Observation Model

observational_model Study_Count
Cohort 119
Case-Only 32
Case-Control 14
Other 4
Case Control 3
NA 2
Ecologic or Community 1

Time Perspective

time_perspective Study_Count
Prospective 121
Retrospective 41
Cross-Sectional 9
Other 2
NA 2

Registries

Studies by Country

Country Study_Count
United States 7
China 3
Germany 3
NA 3
Spain 2
Canada 1
Denmark 1
France 1
Italy 1
Korea, Republic of 1
Luxembourg 1
Singapore 1
Sweden 1
United States|Israel 1

Sites per Study

Site_count Study_Count
1 21
2 2
4 1
6 1
7 1
17 1

Enrollment Metrics

Measure Registries
Min 8.000
1st Qu 81.500
Median 200.000
Mean 1931.296
3rd Qu 775.000
Max 31795.000

Registry Model

observational_model Study_Count
Cohort 20
Case-Only 3
Other 2
Case-Control 1
Case Control 1

Time Perspective

time_perspective Study_Count
Prospective 25
Cross-Sectional 1
Other 1

Follow-up

target_duration Study_Count
5 Years 6
10 Years 4
2 Years 4
3 Years 4
1 Year 3
1 Month 2
30 Days 1
8 Years 1
90 Days 1
99 Years 1

Overview of Studies

Interventional Trials

#If less then 500 trials

Observational Studiess

#If less then 500 studies

nct_id brief_title link overall_status source primary_completion_date
NCT03334708 A Study of Blood Based Biomarkers for Pancreas Adenocarcinoma https://ClinicalTrials.gov/show/NCT03334708 Recruiting Memorial Sloan Kettering Cancer Center 2021-10-30
NCT03266757 Borderline Resectable or Resectable or Advanced Pancreatic Adenocarcinoma https://ClinicalTrials.gov/show/NCT03266757 Completed Hellenic Society of Medical Oncology 2017-02-11
NCT03140592 Pancreatic Cancer Models Developed From EUS Guided Biopsy Tissue https://ClinicalTrials.gov/show/NCT03140592 Recruiting Stony Brook University 2021-01-31
NCT03060642 The Microenvironment in Barrett’s Esophagus https://ClinicalTrials.gov/show/NCT03060642 Enrolling by invitation Columbia University 2021-01-01
NCT03059732 Factors Associated With High Mortality of Gastric Adenocarcinoma in Thailand Versus Japan https://ClinicalTrials.gov/show/NCT03059732 Completed King Chulalongkorn Memorial Hospital 2017-02-28
NCT03059641 Therapeutic ResistAnce and Clonal Evolution Assessed With Liquid Biopsy of NSCLC Patients in China https://ClinicalTrials.gov/show/NCT03059641 Completed Geneplus-Beijing Co. Ltd. 2019-12-31
NCT03033927 Predicting Effective Therapy in Pancreatic Cancer https://ClinicalTrials.gov/show/NCT03033927 Recruiting Memorial Sloan Kettering Cancer Center 2022-01-24
NCT03032913 Diagnostic Accuracy of Circulating Tumor Cells (CTCs) and Onco-exosome Quantification in the Diagnosis of Pancreatic Cancer - PANC-CTC https://ClinicalTrials.gov/show/NCT03032913 Completed University Hospital, Bordeaux 2017-11-13
NCT03030404 Hereditary Gastric Cancer Syndromes: An Integrated Genomic and Clinicopathologic Study of the Predisposition to Gastric Cancer https://ClinicalTrials.gov/show/NCT03030404 Recruiting National Institutes of Health Clinical Center (CC) 2026-12-31
NCT03015389 Wide Area Transepithelial Sample Esophageal Biopsy Combined With Computer Assisted 3-Dimensional Tissue Analysis (WATS3D) For the Detection of High Grade Esophageal Dysplasia and Adenocarcinoma https://ClinicalTrials.gov/show/NCT03015389 Recruiting CDx Diagnostics 2019-02-28
NCT03008980 The Analysis of WATS3D (Wide Area Transepithelial Sample Biopsy With 3-Dimensional Computer-Assisted Analysis) Increased Yield of Barrett’s Esophagus and Esophageal Dysplasia https://ClinicalTrials.gov/show/NCT03008980 Recruiting CDx Diagnostics 2020-12-31
NCT02980536 cSMART Liquid Biopsy and Dynamic Monitor of NSCLC Patients in Inner-Mongolia China https://ClinicalTrials.gov/show/NCT02980536 Active, not recruiting Berry Genomics Co., Ltd. 2018-10-31
NCT02977702 Sarcopenia is an Independent Prognostic Factor for Overall Survival in Patients With Pancreatic Adenocarcinoma https://ClinicalTrials.gov/show/NCT02977702 Completed Institut de Cancérologie de Lorraine 2016-05-31
NCT02976090 Phenotyping of Small Bowel Adenocarcinoma https://ClinicalTrials.gov/show/NCT02976090 Active, not recruiting Assistance Publique - Hôpitaux de Paris 2019-12-31
NCT02975752 EGFRdelEx19 and KRAS Exon 2 Mutation Detection in EBUS-TBNA https://ClinicalTrials.gov/show/NCT02975752 Completed University Hospital, Essen 2016-06-30
NCT02973828 PRIMER: Development of Daily Online Magnetic Resonance Imaging for Magnetic Resonance Image Guided Radiotherapy https://ClinicalTrials.gov/show/NCT02973828 Recruiting Institute of Cancer Research, United Kingdom 2020-06-30
NCT02937155 In the Era of the HPV Vaccine, What Are The Current HPV Subtypes Contributing to High Grade Cervical Dysplasia, Adenocarcinoma in Situ, and Early Cervical Cancer? https://ClinicalTrials.gov/show/NCT02937155 Recruiting Sunnybrook Health Sciences Centre 2019-10-31
NCT02853097 Cell-Free DNA and RNA in Blood fromMetastatic Prostate Cancer Patients https://ClinicalTrials.gov/show/NCT02853097 Recruiting University of Southern California 2020-06-14
NCT02818829 Biological and Clinical Database for Pancreatic Adenocarcinoma https://ClinicalTrials.gov/show/NCT02818829 Recruiting University Hospital, Toulouse 2021-07-31
NCT02812680 The Utility of Circulating Tumour Cells and Plasma microRNA in Esophageal Adenocarcinoma https://ClinicalTrials.gov/show/NCT02812680 Recruiting University Health Network, Toronto 2021-06-30
NCT02810262 Association of Bone and Metabolic Parameters With Overall Survival in Patients With Bone Metastases From Adenocarcinoma Lung Cancer (POUMOS) https://ClinicalTrials.gov/show/NCT02810262 Recruiting Hospices Civils de Lyon 2019-12-31
NCT02801955 Serum and Peritoneal CEA and CA 19-9 for Gastric Adenocarcinoma https://ClinicalTrials.gov/show/NCT02801955 Completed Bezmialem Vakif University 2016-12-31
NCT02790944 Utilizing a Multi-gene Testing Approach to Identify Hereditary Pancreatic Cancer https://ClinicalTrials.gov/show/NCT02790944 Active, not recruiting Ambry Genetics 2020-01-31
NCT02767700 NGS and TME for Evidence-based Treatment of Pancreatic Cancer https://ClinicalTrials.gov/show/NCT02767700 Completed Karolinska University Hospital 2018-03-25
NCT02628379 Outcomes of FoundationOne Directed Therapy in Cancer of Unknown Primary https://ClinicalTrials.gov/show/NCT02628379 Completed Foundation Medicine 2017-03-31
NCT02616211 An Integrated Approach to Treating Recurrent Thoracic Carcinomas Resistant to Tyrosine Kinase Inhibitors https://ClinicalTrials.gov/show/NCT02616211 Active, not recruiting Mayo Clinic 2025-12-31
NCT00912717 Pancreatic Adenocarcinoma Gene Environment Risk Study https://ClinicalTrials.gov/show/NCT00912717 Recruiting University of Pittsburgh 2025-12-31
NCT02981797 Assess Gamma H2AX Positivity in Circulating Prostate Cancer Cells Before and After Radium 223 https://ClinicalTrials.gov/show/NCT02981797 Active, not recruiting H. Lee Moffitt Cancer Center and Research Institute 2017-08-29
NCT02454647 Induction Chemotherapy, Chemoradiotherapy and Surgery in Locally Advanced Gastric Cancer Patients https://ClinicalTrials.gov/show/NCT02454647 Completed Clinica Universidad de Navarra, Universidad de Navarra 2015-03-31
NCT02427269 UNC Barrett’s Esophagus and Esophageal Cancer Biorepository https://ClinicalTrials.gov/show/NCT02427269 Active, not recruiting University of North Carolina, Chapel Hill 2025-05-31
NCT02410603 Isolating and Testing Circulating Tumor DNA and Soluble Immune Markers During the Course of Treatment for Lung Cancer https://ClinicalTrials.gov/show/NCT02410603 Recruiting Mayo Clinic 2020-06-30
NCT02374411 Knowledge, Attitudes, and Practice of Surgeons Toward Nutrition Support in HIPEC Patients https://ClinicalTrials.gov/show/NCT02374411 Completed Edward-Elmhurst Health System 2015-03-31
NCT02370303 A Study to Isolate and Test Circulating Tumor Cells Using the ClearCell® FX EP+ System https://ClinicalTrials.gov/show/NCT02370303 Completed Mayo Clinic 2016-07-09
NCT02306538 Evaluation of Myocardial Changes During BReast Adenocarcinoma Therapy to Detect Cardiotoxicity Earlier With MRI https://ClinicalTrials.gov/show/NCT02306538 Recruiting University Health Network, Toronto 2020-10-31
NCT02228265 Molecular Features and Pathways in Predicting Drug Resistance in Patients With Metastatic Castration-Resistant Prostate Cancer Receiving Enzalutamide https://ClinicalTrials.gov/show/NCT02228265 Active, not recruiting OHSU Knight Cancer Institute 2019-10-01
NCT02132858 Genetic Mutations in Blood and Tissue Samples in Predicting Response to Treatment in Patients With Locally Advanced Rectal Cancer Undergoing Chemoradiation https://ClinicalTrials.gov/show/NCT02132858 Active, not recruiting Fox Chase Cancer Center 2018-07-14
NCT02129036 Ovarian Clear Cell Adenocarcinoma Review https://ClinicalTrials.gov/show/NCT02129036 Completed Cathay General Hospital 2012-12-31
NCT02093000 A Study Examining Maintenance Bevacizumab (Avastin®) Monotherapy in Participants With Advanced Lung Adenocarcinoma https://ClinicalTrials.gov/show/NCT02093000 Completed Hoffmann-La Roche 2018-01-31
NCT02075905 Stratifying Risk in Barrett’s Esophagus: A Pilot Study for Biomarker-based Patient Management https://ClinicalTrials.gov/show/NCT02075905 Completed University of North Carolina, Chapel Hill 2015-08-31
NCT01315548 Contrast Enhanced Harmonic Endoscopic Ultrasound (CEH-EUS) in Focal Pancreatic Masses https://ClinicalTrials.gov/show/NCT01315548 Completed University of Medicine and Pharmacy Craiova 2012-04-30
NCT02022995 Investigation of Methylation of EGFR in the Response of the Cetuximab in Metastatic Colorectal Cancer Patients https://ClinicalTrials.gov/show/NCT02022995 Completed National Taiwan University Hospital 2016-01-31
NCT01269970 Early Metabolic Response in Locally Advanced Esophageal Cancer Undergoing Induction Chemoradiotherapy https://ClinicalTrials.gov/show/NCT01269970 Completed Universitaire Ziekenhuizen Leuven 2008-07-31
NCT02050997 Plasma Biomarkers P-DAC, V1 https://ClinicalTrials.gov/show/NCT02050997 Active, not recruiting Cancer Trials Ireland 2021-12-31
NCT03838588 The Tracking Molecular Evolution for NSCLC (T-MENC) Study https://ClinicalTrials.gov/show/NCT03838588 Recruiting Geneplus-Beijing Co. Ltd. 2021-12-31
NCT02017509 Immunoscore in Rectal Cancer https://ClinicalTrials.gov/show/NCT02017509 Completed Providence Health & Services 2018-07-17
NCT02005965 Low Rectal Cancer Study (MERCURY II) https://ClinicalTrials.gov/show/NCT02005965 Active, not recruiting Royal Marsden NHS Foundation Trust 2016-03-11
NCT01995942 Molecular, Pathologic and MRI Investigation of the Prognostic and Redictive Importance of Extramural Venous Invasion in Rectal Cancer (MARVEL) Trial https://ClinicalTrials.gov/show/NCT01995942 Active, not recruiting Royal Marsden NHS Foundation Trust 2017-02-02
NCT01992861 MRI and PET Imaging in Predicting Treatment Response in Patients With Stage IB-IVA Cervical Cancer https://ClinicalTrials.gov/show/NCT01992861 Recruiting University of Washington 2021-09-30
NCT01989624 PAncreatic Adenocarcinoma in Hospital https://ClinicalTrials.gov/show/NCT01989624 Active, not recruiting Centre Hospitalier Departemental Vendee 2015-12-31
NCT04452058 CT-based Radiomic Algorithm for Assisting Surgery Decision and Predicting Immunotherapy Response of NSCLC https://ClinicalTrials.gov/show/NCT04452058 Recruiting Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University 2021-12-01
NCT01953640 Gene Expression in Patients With Metastatic Prostate Cancer Receiving CYP-17 Inhibition Therapy https://ClinicalTrials.gov/show/NCT01953640 Active, not recruiting Mayo Clinic 2015-12-03
NCT01882478 Cryotherapy -BEATS-RF Ablation Trial https://ClinicalTrials.gov/show/NCT01882478 Active, not recruiting Mayo Clinic 2020-06-30
NCT01857908 A Correlative Study of Biomarkers of Resistance in Patients With Castrate Resistant Prostate Cancer Treated With Abiraterone https://ClinicalTrials.gov/show/NCT01857908 Completed University Health Network, Toronto 2014-11-30
NCT01836133 An Observational Study of Tarceva (Erlotinib) in Participants With Locally Advanced or Metastatic Adenocarcinoma Non-Small Cell Lung Cancer (ELEMENT) https://ClinicalTrials.gov/show/NCT01836133 Completed Hoffmann-La Roche 2016-01-31
NCT01827852 AVAdeno Study: An Observational Study of First-Line Avastin (Bevacizumab) in Patients With Adenocarcinoma of the Lung https://ClinicalTrials.gov/show/NCT01827852 Completed Hoffmann-La Roche 2017-05-31
NCT01824966 Signet Ring Cell Carcinoma in Esophageal Adenocarcinoma https://ClinicalTrials.gov/show/NCT01824966 Completed University Hospital, Gasthuisberg 2012-12-31
NCT01787864 Prevalence of Dysplasia of the Gastric Cardia https://ClinicalTrials.gov/show/NCT01787864 Completed University of North Carolina, Chapel Hill 2017-05-31
NCT01785888 Europe-Japan Diagnostic Study for EGFR Testing https://ClinicalTrials.gov/show/NCT01785888 Completed AstraZeneca 2014-04-30
NCT01766986 Staging and Outcome Depending on Surgical Treatment in Adenocarcinomas of the Oesophagogastric Junction https://ClinicalTrials.gov/show/NCT01766986 Completed Universitätsklinikum Hamburg-Eppendorf 2013-01-31
NCT01764659 4D-CT for Pancreatic Adenocarcinoma in Radiotherapy Simulation https://ClinicalTrials.gov/show/NCT01764659 Completed University of Maryland, Baltimore 2014-10-31
NCT01742312 Effects of Chemotherapy on Muscle Mass and Exercise Performance in Patients With Oesophageal Cancer. https://ClinicalTrials.gov/show/NCT01742312 Completed University of Nottingham 2013-01-31
NCT01731379 Optical Detection of Peripheral Nerve Bundles During Surgery https://ClinicalTrials.gov/show/NCT01731379 Completed Philips Healthcare 2014-01-31
NCT01511653 Validation of Colon Biomarkers for the Early Detection of Colorectal Adenocarcinoma https://ClinicalTrials.gov/show/NCT01511653 Completed University of Michigan 2019-04-30
NCT01474564 Feasibility of Obtaining and Characterizing Circulating Tumorigenic Cells in Patients With Pancreatic Adenocarcinoma https://ClinicalTrials.gov/show/NCT01474564 Completed Memorial Sloan Kettering Cancer Center 2019-10-31
NCT01396928 Study of Two Techniques of Rectal Reservoir in Low Anterior Resection of Rectum https://ClinicalTrials.gov/show/NCT01396928 Completed Hospital Universitari de Bellvitge 2005-12-31
NCT01393483 Evaluate Mesothelin as a Biomarker for the Clinical Management of Esophageal Adenocarcinoma (EAC) https://ClinicalTrials.gov/show/NCT01393483 Recruiting Memorial Sloan Kettering Cancer Center 2020-09-30
NCT04435067 Evaluation of Clinical, Radiomics and Molecular Features of Lung Metastasis in PDAC Patients (LUMACA Trial) https://ClinicalTrials.gov/show/NCT04435067 Recruiting IRCCS San Raffaele 2021-12-31
NCT04430127 The Role of Quantitative Measures on Dual-energy CT in the Prediction of Colorectal Adenocarcinoma https://ClinicalTrials.gov/show/NCT04430127 Recruiting Hôpital Fribourgeois 2021-09-30
NCT04423731 Neoadjuvant Chemotherapy in Borderline Resectable and Locally Advanced Pancreatic Cancer https://ClinicalTrials.gov/show/NCT04423731 Recruiting Oslo University Hospital 2023-12-31
NCT04406571 Reorganization of the Healthcare System During COVID-19 Pandemic: Impact on Management of Patients With Exocrine Pancreatic Cancer https://ClinicalTrials.gov/show/NCT04406571 Recruiting CHU de Reims 2021-11-30
NCT04406831 The Role of MicroRNA in the Diagnosis, Prognosis and Response to Treatment in Pancreatic Cancer https://ClinicalTrials.gov/show/NCT04406831 Recruiting Western Connecticut Health Network 2025-04-30
NCT04396093 Analysis Of The Anxiety-Depressive Pattern, Quality Of Life And Assessment Of Personality in Patients With Pancreatic Ductal Adenocarcinoma (PACT24) https://ClinicalTrials.gov/show/NCT04396093 Recruiting IRCCS San Raffaele 2021-05-10
NCT04384770 CT-guided Stereotactic Body Radiation Therapy and MRI-guided Stereotactic Body Radiation Therapy for Prostate Cancer, MIRAGE Study https://ClinicalTrials.gov/show/NCT04384770 Recruiting Jonsson Comprehensive Cancer Center 2026-04-01
NCT04374175 SERum-bank for PANcreatic Cancer https://ClinicalTrials.gov/show/NCT04374175 Recruiting Centre Hospitalier Universitaire de Saint Etienne 2022-01-01
NCT04365790 Investigation of Gene Mutations in Patients With Triple-negative and Patients With HER2+ Breast Cancer Adenocarcinoma https://ClinicalTrials.gov/show/NCT04365790 Recruiting Hellenic Cooperative Oncology Group 2020-12-31
NCT04291612 Observational Study of Women With Endometrial Cancer Who Receive the Standard Treatment for Their Disease https://ClinicalTrials.gov/show/NCT04291612 Recruiting Memorial Sloan Kettering Cancer Center 2024-02-26
NCT04286386 Development and Evaluation of a Quantitative HP MRI for Clinical Prostate Cancer Exam https://ClinicalTrials.gov/show/NCT04286386 Recruiting M.D. Anderson Cancer Center 2022-02-28
NCT04241367 Verification of Predictive Biomarkers for Pancreatic Cancer Treatment Using Multicenter Liquid Biopsy https://ClinicalTrials.gov/show/NCT04241367 Recruiting National Cancer Center, Korea 2021-03-20
NCT04248231 CINSARC Genomic Signature as Predictor of Resectability of Ovarian Adenocarcinoma https://ClinicalTrials.gov/show/NCT04248231 Recruiting Institut Claudius Regaud 2020-09-15
NCT04232020 A Retrospective Validations Microsatellite Instability (MSI) Testing v Mismatch Repair (MMR) in Gastric Adenocarcinoma https://ClinicalTrials.gov/show/NCT04232020 Recruiting Royal Cornwall Hospitals Trust 2020-07-31
NCT04227886 Study on Predictive Biomarkers of Neoadjuvant Chemoradiotherapy for Rectal Cancer https://ClinicalTrials.gov/show/NCT04227886 Recruiting Fudan University 2020-12-31
NCT04202614 Prognostic Role of Positron Emission Tomography and Computed Tomography Parameters in Stage I Lung Adenocarcinoma https://ClinicalTrials.gov/show/NCT04202614 Recruiting IRCCS San Raffaele 2020-01-02
NCT04183218 Characterizing Chemo-Radiotherapy Treatment-Related Cardiac Changes in Non-metastatic, Non-recurrent Lung and Esophageal Cancer Patients https://ClinicalTrials.gov/show/NCT04183218 Recruiting Mayo Clinic 2021-09-23
NCT04165759 Prospective Radiological Study of HRCT to Predict Pathological Noninvasiveness in NSCLC https://ClinicalTrials.gov/show/NCT04165759 Recruiting Fudan University 2020-09-30
NCT04151524 Classification of Adenocarcinoma of the Esophagogastric Junction https://ClinicalTrials.gov/show/NCT04151524 Active, not recruiting St. James’s Hospital, Ireland 2019-12-25
NCT04148378 A Pilot Study to Explore the Role of Gut Flora in Colorectal Cancer https://ClinicalTrials.gov/show/NCT04148378 Recruiting ProgenaBiome 2023-03-31
NCT04141566 Pseudo Continent Perineal Colostomy vs Permanent Left Iliac Colostomy After Abdominoperineal Resection for Ultra Low Rectal Adenocarcinoma https://ClinicalTrials.gov/show/NCT04141566 Recruiting Moroccan Society of Surgery 2020-06-30
NCT04122833 Impact of Concomitant Genetic Alterations in EGFR Mutated Adenocarcinoma by NGS Analysis: A Multicenter Study https://ClinicalTrials.gov/show/NCT04122833 Recruiting Konkuk University Medical Center 2020-09-30
NCT04109105 Study for the Efficacy and Security Analysis in the Protection of Ileocolic Anastomosis Conducted in Laparoscopic Right Hemicolectomy Because of Colon Cancer, Using a NHS-PEG Coated Collagen Patch. https://ClinicalTrials.gov/show/NCT04109105 Recruiting Fundación Pública Andaluza para la gestión de la Investigación en Sevilla 2019-12-15
NCT04086680 The Detection of EGFR Mutations in Liquid Based Cytology Samples https://ClinicalTrials.gov/show/NCT04086680 Completed Royal Cornwall Hospitals Trust 2020-02-24
NCT04063800 Prediction of the Risk of Biochemical Relapse After Radical Prostatectomy for Prostate Cancer Using Radomics on Pre-therapeutic MRI https://ClinicalTrials.gov/show/NCT04063800 Completed University Hospital, Brest 2018-08-28
NCT04030338 Prostate-Specific Membrane Antigen (PSMA) PET Scans in People Prostate Cancer https://ClinicalTrials.gov/show/NCT04030338 Recruiting Memorial Sloan Kettering Cancer Center 2022-07-31
NCT04005118 Human Intestinal Microbiome and Surgical Outcomes in Patients Undergoing Colorectal Cancer Surgery https://ClinicalTrials.gov/show/NCT04005118 Recruiting Assistance Publique - Hôpitaux de Paris 2020-04-01
NCT03997162 Early Recovery After Surgery Protocol in Improving Quality of Life in Participants With Stage 0-IIIC Gastric Cancer Undergoing Surgery https://ClinicalTrials.gov/show/NCT03997162 Recruiting City of Hope Medical Center 2020-08-30
NCT03996993 Defining Recurrent Disease With Axuminâ„¢ https://ClinicalTrials.gov/show/NCT03996993 Recruiting Cancer Center of Irvine 2020-09-30
NCT03987828 Noncurative Endoscopic Resection of Colorectal Adenocarcinoma https://ClinicalTrials.gov/show/NCT03987828 Recruiting Istituto Clinico Humanitas 2020-02-29
NCT03963739 Effect of Treatment on Work Experience in Patients With Stage I-III Prostate Cancer https://ClinicalTrials.gov/show/NCT03963739 Recruiting Wake Forest University Health Sciences 2021-09-01
NCT03899870 Factors Predicting Recurrence in Rectal Cancer After Surgery https://ClinicalTrials.gov/show/NCT03899870 Completed Université de Sousse 2015-12-31
NCT03840460 A Prospective Translational Tissue Collection Study in Early and Advanced Pancreatic Ductal Adenocarcinoma and Pancreatic Neuroendocrine Tumours to Enable Further Disease Characterisation and the Development of Potential Predictive and Prognostic Biomarkers https://ClinicalTrials.gov/show/NCT03840460 Recruiting Royal Marsden NHS Foundation Trust 2023-01-10
NCT03843905 Predictive Value of Innovative Prognostic Markers (Gut Microbiota, Sarcopenia, Metabolic Syndrome and Obesity) on Surgical and Oncologic Results in the Management of Sporadic Colorectal Adenocarcinoma. https://ClinicalTrials.gov/show/NCT03843905 Recruiting University Hospital, Clermont-Ferrand 2018-11-15
NCT03800212 Survival and Description of Care for Patients With Degenerate Vaterian Ampulloma https://ClinicalTrials.gov/show/NCT03800212 Recruiting Federation Francophone de Cancerologie Digestive 2021-12-15
NCT03794128 A Study of Personalized Neoantigen Cancer Vaccines https://ClinicalTrials.gov/show/NCT03794128 Active, not recruiting Gritstone Oncology, Inc. 2020-01-17
NCT03780023 CCRO044: Quality of Life Assessments Associated With a Physician Communication Intervention for Prostate Cancer Patients https://ClinicalTrials.gov/show/NCT03780023 Recruiting University of California, Davis 2021-07-17
NCT03771508 Prospective Collection of PillCam SB3 Videos and Raw Data Files for Future Developments (SODA) https://ClinicalTrials.gov/show/NCT03771508 Recruiting Medtronic - MITG 2021-01-31
NCT03770117 Study of the Effect of Prehabilitation on Markers of Sarcopenia in Patients Undergoing Pancreatoduodenectomy for Malignant Disease https://ClinicalTrials.gov/show/NCT03770117 Recruiting Manchester University NHS Foundation Trust 2020-07-31
NCT03765736 Genetic Testing in Screening Patients With Metastatic or Unresectable Colon or Rectal Cancer for a COLOMATE Trial https://ClinicalTrials.gov/show/NCT03765736 Recruiting Academic and Community Cancer Research United 2023-11-12
NCT03742869 HPV Integration and Tumorigenesis of Uterine Cervical Adenocarcinoma https://ClinicalTrials.gov/show/NCT03742869 Recruiting Peking Union Medical College Hospital 2021-11-23
NCT03716414 Evaluation of the Efficacy for Sentinel Lymph Node Policy in High-risk Endometrial Carcinoma https://ClinicalTrials.gov/show/NCT03716414 Completed Fudan University 2020-02-16
NCT03707574 Genetic Analysis of Blood and Tissue Samples From Patients With Advanced Cancer, Moonshot Study https://ClinicalTrials.gov/show/NCT03707574 Recruiting National Cancer Institute (NCI) 2023-05-01
NCT03706235 Colvera for Detection of Disease Recurrence https://ClinicalTrials.gov/show/NCT03706235 Active, not recruiting Clinical Genomics Pathology 2019-08-16
NCT03699163 The Colorectal Breath Analysis (COBRA) Study https://ClinicalTrials.gov/show/NCT03699163 Recruiting Imperial College London 2020-06-03
NCT03695835 A Data Collection Study for Patients With Adenocarcinoma Treated With the MyVaccx Immunotherapy Regimen. https://ClinicalTrials.gov/show/NCT03695835 Active, not recruiting Gary Onik MD 2019-07-08
NCT03693378 A Study of IMMrayâ„¢ PanCan-d Test for Early Detection of Pancreatic Cancer in High-risk Groups https://ClinicalTrials.gov/show/NCT03693378 Recruiting Immunovia, Inc. 2020-10-31
NCT03673423 Evaluation of the Interobserver Agreement on the Resectability Status of Patients With a Pancreatic Cancer https://ClinicalTrials.gov/show/NCT03673423 Recruiting Ospedale San Raffaele 2019-03-05
NCT03659903 Pancreaticoduodenectomy in Elderly Pancreatic Ductal Adenocarcinoma Patients https://ClinicalTrials.gov/show/NCT03659903 Completed The First Affiliated Hospital of Dalian Medical University 2013-12-13
NCT03619668 Chemo-radiotherapy as Main Treatment Strategy for Rectal Cancer. Can we Provide a More Precise and Effective Treatment https://ClinicalTrials.gov/show/NCT03619668 Recruiting Aalborg University Hospital 2020-06-30
NCT03611686 Observatory of Patients With Metastatic ProstAte Adenocarcinoma That is Resistant to Castration and Multi-LinE Strategies https://ClinicalTrials.gov/show/NCT03611686 Recruiting University Hospital, Rouen 2026-04-30
NCT03616431 Pancreatic Cancer Dietary Assessment Study https://ClinicalTrials.gov/show/NCT03616431 Recruiting The Christie NHS Foundation Trust 2022-05-31
NCT03601689 Predictive Factors of Disease-free Survival After Complete Pathological Response to Neoadjuvant Radiotherapy in Rectal Adenocarcinoma https://ClinicalTrials.gov/show/NCT03601689 Completed Moroccan Society of Surgery 2013-12-31
NCT03578939 Next Generation Sequencing of Tumor Cells in Locally Advanced Pancreatic Adenocarcinoma https://ClinicalTrials.gov/show/NCT03578939 Active, not recruiting Istituto Clinico Humanitas 2020-02-29
NCT03557528 Role of Low Inferior Mesenteric Artery Ligation During Laparoscopic Surgery for Rectosigmoid Cancer https://ClinicalTrials.gov/show/NCT03557528 Completed University of Roma La Sapienza 2016-12-31
NCT03544255 Drug Screening of Pancreatic Cancer Organoids Developed From EUS-FNA Guided Biopsy Tissues https://ClinicalTrials.gov/show/NCT03544255 Recruiting The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School 2020-12-01
NCT03529968 Siewert Type I-II: CT, PET-CT, EUS Sensitivity/Specificity for the Assessment of Lymph Node Metastases https://ClinicalTrials.gov/show/NCT03529968 Completed University of Bologna 2017-12-31
NCT03526328 DCLK1 as a Marker/Indicator of Stem Cell Response in Barrett’s Esophagus/Esophageal Adenocarcinoma https://ClinicalTrials.gov/show/NCT03526328 Completed University of Oklahoma 2019-08-13
NCT03517332 Circulating Tumor DNA Exposure in Peripheral Blood https://ClinicalTrials.gov/show/NCT03517332 Recruiting Quantgene Inc. 2019-12-31
NCT03503643 Hemi-Gland Cryoablation for Prostate Cancer at UCLA https://ClinicalTrials.gov/show/NCT03503643 Enrolling by invitation University of California, Los Angeles 2021-12-31
NCT03494803 Detection of Prostate Cancer With Non-invasive Method Based on DNA Methylation of Circulated Tumor DNA, PBMC https://ClinicalTrials.gov/show/NCT03494803 Recruiting HKGepitherapeutics 2021-12-01
NCT03474341 Preoperative Image-guided Identification of Response to Neoadjuvant Chemoradiotherapy in Esophageal Cancer https://ClinicalTrials.gov/show/NCT03474341 Recruiting UMC Utrecht 2020-08-31
NCT03472716 The βIG-H3 Protein: a New Marker in PANCreatic Adenocarcinoma (BIGHPANC) https://ClinicalTrials.gov/show/NCT03472716 Recruiting Centre Leon Berard 2021-05-31
NCT03462524 Neoadjuvant Therapy for Esophageal Cancer and Cardiopulmonary Physiology https://ClinicalTrials.gov/show/NCT03462524 Completed St. James’s Hospital, Ireland 2016-01-01
NCT03455452 An Observational Study of Nivolumab in Participants With Advanced Kidney Cancer https://ClinicalTrials.gov/show/NCT03455452 Recruiting Bristol-Myers Squibb 2022-01-18
NCT03416101 Siewert Type II Esophageal Adenocarcinoma: Relationship Between Histology and Survival https://ClinicalTrials.gov/show/NCT03416101 Completed University of Bologna 2017-06-30
NCT01216813 Study of Physical and Psychosocial Rehabilitation Needs of Patients After Diagnosis and Treatment of Upper Gastrointestinal Cancer or Gynecological Cancer https://ClinicalTrials.gov/show/NCT01216813 Completed National Cancer Institute (NCI) 2010-10-31
NCT01219829 Pancreatic Intraepithelial Neoplasia (PanIN) and the Association With Recurrence of Pancreatic Adenocarcinoma https://ClinicalTrials.gov/show/NCT01219829 Active, not recruiting Columbia University 2020-05-31
NCT01208467 Prognostic Biomarkers in Patients With Endometrial Cancer https://ClinicalTrials.gov/show/NCT01208467 Completed Gynecologic Oncology Group 2014-05-31
NCT01167972 Observational Study on the Management of Patients With Non Small Cell Lung Cancer Adenocarcinoma https://ClinicalTrials.gov/show/NCT01167972 Completed AstraZeneca 2012-09-30
NCT01135823 Symptom Assessment With Patient Surveys https://ClinicalTrials.gov/show/NCT01135823 Completed Stanford University 2008-06-30
NCT01129167 Frequency of Methods of Local Invasion of Pancreatic Adenocarcinoma https://ClinicalTrials.gov/show/NCT01129167 Active, not recruiting Columbia University 2020-07-31
NCT01077817 Observational Study of Incidence Rates of Esophageal Cancer in Women Taking Medications for the Prevention or Treatment of Osteoporosis (MK-0217A-352) https://ClinicalTrials.gov/show/NCT01077817 Completed Merck Sharp & Dohme Corp. 2012-02-16
NCT01014286 Lung Cancer Mutation Consortium Protocol https://ClinicalTrials.gov/show/NCT01014286 Active, not recruiting University of Colorado, Denver 2020-09-30
NCT00923026 Follow Up Protocol for Subjects Previously Enrolled on NCI Surgery Branch Studies https://ClinicalTrials.gov/show/NCT00923026 Enrolling by invitation National Institutes of Health Clinical Center (CC) NA
NCT00909350 Micro-RNA (miR) Expression in Upper Gastrointestinal Mucosal Tissue https://ClinicalTrials.gov/show/NCT00909350 Completed Mayo Clinic 2008-11-30
NCT00909103 Endoscopic Ultrasound Elastography in Pancreatic Masses https://ClinicalTrials.gov/show/NCT00909103 Completed University of Medicine and Pharmacy Craiova 2009-11-30
NCT00897442 Collecting Tumor Samples From Patients With Gynecological Tumors https://ClinicalTrials.gov/show/NCT00897442 Completed Gynecologic Oncology Group 2016-01-31
NCT00855946 Proteomic Approach Using Matrix-assisted Laser Desorption/Ionization Tandem Time-of-flight (MALDI-TOF/TOF) of Tumor Response in Rectal Carcinoma After Radiochemotherapy https://ClinicalTrials.gov/show/NCT00855946 Completed University Hospital, Bordeaux 2012-05-31
NCT04370860 Optimal EGFR TKIs Treatment Strategies for Lung Adenocarcinoma Harboring EGFR Exon 19 Deletion Variants https://ClinicalTrials.gov/show/NCT04370860 Recruiting National Taiwan University Hospital 2025-03-31
NCT04349384 Audit of Surgery for Colorectal Cancer https://ClinicalTrials.gov/show/NCT04349384 Completed Institut National d’Oncologie, Morocco 2019-12-31
NCT04146077 Active Surveillance for Low Risk Prostate Cancer https://ClinicalTrials.gov/show/NCT04146077 Recruiting I.M. Sechenov First Moscow State Medical University 2024-10-31
NCT04161781 A Study of PET Scans With the Radioactive Tracer 18F-BMS-986229 in Patients With Esophageal, Stomach, or Gastroesophageal Junction Cancer https://ClinicalTrials.gov/show/NCT04161781 Recruiting Memorial Sloan Kettering Cancer Center 2021-11-12
NCT03871790 Peptide-based Immunization for Colon- and and Pancreas-carcinoma https://ClinicalTrials.gov/show/NCT03871790 Recruiting Centogene AG Rostock 2021-04-01
NCT01106781 A Non-interventional Survey on the EGFR (Epidermal Growth Factor Receptor) Mutation Status in Completely Resected Chinese Non-Small Cell Lung Cancer (NSCLC) Patients With Adenocarcinoma Histology https://ClinicalTrials.gov/show/NCT01106781 Completed AstraZeneca 2014-01-31
NCT03982446 Germline Mutations in Pancreatic Adenocarcinoma https://ClinicalTrials.gov/show/NCT03982446 Active, not recruiting Hellenic Cooperative Oncology Group 2019-11-01
NCT03940846 CT-based Radiomic Signature Can Identify Adenocarcinoma Lung Tumor Histology https://ClinicalTrials.gov/show/NCT03940846 Active, not recruiting Maastricht University 2020-10-31
NCT03490604 Ambulatory Measurement of Physical Activity in Pancreatic Cancer Patients https://ClinicalTrials.gov/show/NCT03490604 Recruiting Centre Hospitalier Universitaire Dijon 2021-07-31
NCT03451812 Molecular PET/MR Imaging in Vivo Validation of Biomarker for Human Prostate Cancer https://ClinicalTrials.gov/show/NCT03451812 Recruiting Chang Gung Memorial Hospital 2019-12-31
NCT04449406 Early Detection of Pancreatic Adenocarcinoma (PDAC) Using a Panel of Biomarkers https://ClinicalTrials.gov/show/NCT04449406 Active, not recruiting Queen Mary University of London 2024-01-31
NCT01862666 A Comparison of Volumetric Laser Endomicroscopy (VLE) and Endoscopic Mucosal Resection (EMR) in Patients With Barrett’s Dysplasia or Intramucosal Adenocarcinoma https://ClinicalTrials.gov/show/NCT01862666 Completed NinePoint Medical 2015-01-31
NCT01635595 Nodal Status in Adenocarcinoma of the Esophagus an Cardia https://ClinicalTrials.gov/show/NCT01635595 Completed University of Bologna NA
NCT02869802 Prospectively Defining Metastatic Pancreatic Ductal Adenocarcinoma Subtypes by Comprehensive Genomic Analysis https://ClinicalTrials.gov/show/NCT02869802 Recruiting British Columbia Cancer Agency 2023-09-30
NCT01703650 Role of Perfusion CT in Pancreatic Cancer https://ClinicalTrials.gov/show/NCT01703650 Active, not recruiting Seoul National University Hospital 2015-12-31
NCT04219137 Molecular Characteristics of Gastroesophageal Adenocarcinoma (MOCHA): A Prospective Feasibility Study https://ClinicalTrials.gov/show/NCT04219137 Recruiting University Health Network, Toronto 2021-11-30
NCT03973736 Impact of Multidisciplinary and Radiologic Review on Outcome of Pancreatic Cancer Patients: an Observational Study https://ClinicalTrials.gov/show/NCT03973736 Completed Azienda Unità Sanitaria Locale Reggio Emilia 2018-07-15
NCT00773656 Patients Overexposed for a Prostate Adenocarcinoma https://ClinicalTrials.gov/show/NCT00773656 Completed Assistance Publique - Hôpitaux de Paris 2013-05-31
NCT00644254 The Prognostic Impact of Extracapsular Lymph Node Involvement in Ductal Pancreatic Adenocarcinoma https://ClinicalTrials.gov/show/NCT00644254 Completed KU Leuven 2007-11-30
NCT00588367 CT Pancreas Perfusion https://ClinicalTrials.gov/show/NCT00588367 Completed Mayo Clinic 2009-02-28
NCT00586989 Endoscopic Tri-Modal Imaging in Patients With Barrett’s Esophagus https://ClinicalTrials.gov/show/NCT00586989 Completed Mayo Clinic 2010-02-28
NCT00587314 The Effect of Ablation Therapy on Barrett’s Esophagus https://ClinicalTrials.gov/show/NCT00587314 Enrolling by invitation Mayo Clinic 2020-01-31
NCT00586872 Endoscopic Mucosal Resection (EMR) in Barrett’s Esophagus https://ClinicalTrials.gov/show/NCT00586872 Enrolling by invitation Mayo Clinic 2025-10-31
NCT00574327 Progression of Gastroesophageal Reflux Disease and Barrett’s Esophagus and the Creation of a Barrett’s Registry https://ClinicalTrials.gov/show/NCT00574327 Recruiting Midwest Biomedical Research Foundation 2023-10-31
NCT00547742 Correlation of PET-CT Studies With Serum Protein Analysis https://ClinicalTrials.gov/show/NCT00547742 Completed Stanford University 2009-03-31
NCT00495924 Perioperative Cancer Cell Dissemination and Systemic Immune Suppression in Resectable Ductal Pancreatic Adenocarcinoma https://ClinicalTrials.gov/show/NCT00495924 Completed KU Leuven NA
NCT00460356 Glycoprotein and Glycan in Tissue and Blood Samples of Patients With Stage IB-IVA Cervical Cancer Undergoing Surgery to Remove Pelvic and Abdominal Lymph Nodes https://ClinicalTrials.gov/show/NCT00460356 Completed Gynecologic Oncology Group 2016-07-16
NCT00349830 Novel Serum Markers for Monitoring Response to Anti-Cancer Therapy https://ClinicalTrials.gov/show/NCT00349830 Recruiting Stanford University 2022-01-31
NCT00288119 Genetic Determinants of Barrett’s Esophagus and Esophageal Adenocarcinoma https://ClinicalTrials.gov/show/NCT00288119 Recruiting University Hospitals Cleveland Medical Center 2022-04-30
NCT00097578 A Study of Avastin With Chemotherapy for Treatment of Metastatic or Advanced and Unresectable Colorectal Adenocarcinoma https://ClinicalTrials.gov/show/NCT00097578 Completed Genentech, Inc. 2008-07-31

Registries

#If less then 500 registries

nct_id brief_title link overall_status source primary_completion_date
NCT03284151 Focused Stereotactic Radiation Treatment of Prostatic Adenocarcinoma https://ClinicalTrials.gov/show/NCT03284151 Recruiting Centre Francois Baclesse, Luxembourg 2020-01-31
NCT03024450 Trastuzumab Based Therapy in HER2 Positive AGC https://ClinicalTrials.gov/show/NCT03024450 Completed Shanghai Zhongshan Hospital 2016-05-31
NCT02974764 Changes in Biomarkers From Blood Over Time in Patients With Pancreatic Adenocarcinoma https://ClinicalTrials.gov/show/NCT02974764 Completed Johns Hopkins University 2018-12-31
NCT02818231 Mechanisms of Cancerogenesis of Woodworkers Adenocarcinomas https://ClinicalTrials.gov/show/NCT02818231 Completed Central Hospital, Nancy, France 2016-09-30
NCT02781285 Effect Study of Clinical Outcomes of Traditional Chinese Medicine to Advanced Gastric Cancer by Propensity Score https://ClinicalTrials.gov/show/NCT02781285 Recruiting Shanghai University of Traditional Chinese Medicine 2020-10-31
NCT02781012 Project Survival-Prospective Biomarker Discovery https://ClinicalTrials.gov/show/NCT02781012 Active, not recruiting Pancreatic Cancer Research Team 2022-02-28
NCT02624115 FAZA PET as Biomarker for Hypoxia in Rectal Cancer https://ClinicalTrials.gov/show/NCT02624115 Completed University Health Network, Toronto 2019-06-09
NCT02305368 Evaluation of Interest Chemo-oncogramme in Patients With Colonic Adenocarcinoma Stage 4 https://ClinicalTrials.gov/show/NCT02305368 Completed University Hospital, Limoges 2012-03-31
NCT02206360 Pancreatic Cancer Early Detection Program https://ClinicalTrials.gov/show/NCT02206360 Recruiting White Plains Hospital 2024-03-31
NCT02127359 Whole-Exome Sequencing (WES) of Cancer Patients https://ClinicalTrials.gov/show/NCT02127359 Active, not recruiting Dana-Farber Cancer Institute 2017-04-30
NCT02082886 HIPEC For Peritoneal Surface Malignancies Including Carcinomatosis or Sarcomatosis ‐ Data Registry https://ClinicalTrials.gov/show/NCT02082886 Completed Edward-Elmhurst Health System 2020-01-31
NCT02077673 Gastric Microperfusion in Patients Undergoing Gastroesophageal Resections https://ClinicalTrials.gov/show/NCT02077673 Completed Rigshospitalet, Denmark 2015-01-31
NCT01983410 A Registry for BRCA Mutation Carriers With Pancreatic Ductal Adenocarcinoma https://ClinicalTrials.gov/show/NCT01983410 Recruiting Memorial Sloan Kettering Cancer Center 2020-11-30
NCT01776346 Barrett’s Esophagus Patient Registry https://ClinicalTrials.gov/show/NCT01776346 Recruiting Massachusetts General Hospital 2021-12-31
NCT04291651 UCSF Panc Cyst Registry https://ClinicalTrials.gov/show/NCT04291651 Recruiting University of California, San Francisco 2030-01-01
NCT04290806 Registry Platform Gastric/Esophageal Cancer (SAPHIR) https://ClinicalTrials.gov/show/NCT04290806 Recruiting iOMEDICO AG 2024-12-31
NCT04245644 Efficacy of Chemopreventive Agents on Disease-free and Overall Survival in Patients With Pancreatic Ductal Adenocarcinoma: The CAOS Study https://ClinicalTrials.gov/show/NCT04245644 Recruiting IRCCS San Raffaele 2024-02-28
NCT04147403 A Study of Extended Total Mesopancreas Excision(eTME) for Pancreatic Head Adenocarcinoma. https://ClinicalTrials.gov/show/NCT04147403 Recruiting Shanghai Jiao Tong University School of Medicine 2018-10-31
NCT04119362 PARAGON Platform for Outcome, Quality of Life, and Translational Research on Pancreatic Cancer https://ClinicalTrials.gov/show/NCT04119362 Recruiting Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest 2029-01-31
NCT04099134 PACAREG: a Multicenter Registry Trial in Pancreatic Ductal Adencarcinoma https://ClinicalTrials.gov/show/NCT04099134 Recruiting University of Ulm 2028-10-31
NCT03992599 Prospective Study of Oncologic Outcomes After Laparoscopic Modified Complete Mesocolic Excision for Non-metastatic Right Colon Cancer [PIONEER Study] https://ClinicalTrials.gov/show/NCT03992599 Enrolling by invitation Yonsei University 2024-07-31
NCT03922828 Lung Nodule Prospective Database https://ClinicalTrials.gov/show/NCT03922828 Recruiting Singapore General Hospital 2023-04-30
NCT03803891 Endoscopic Full-Thickness Resection In Colon https://ClinicalTrials.gov/show/NCT03803891 Recruiting Fundació Institut Germans Trias i Pujol 2020-01-31
NCT03724994 Chemotherapy, Host Response and Molecular Dynamics in Periampullary Cancer https://ClinicalTrials.gov/show/NCT03724994 Recruiting Lund University 2022-09-01
NCT03683446 Trends and Outcomes in Laparoscopic Versus Open Surgery for Rectal Cancer https://ClinicalTrials.gov/show/NCT03683446 Completed The Methodist Hospital System 2017-01-30
NCT03641105 Investigation of the Contents and Prognostic Values of Glucose Metabolism Molecules in Patients With Lung Adenocarcinoma https://ClinicalTrials.gov/show/NCT03641105 Active, not recruiting Shanghai Zhongshan Hospital 2019-03-01
NCT03570502 Incidence of POPF in the Resection of the Left Pancreas With RFAT https://ClinicalTrials.gov/show/NCT03570502 Recruiting Hospital del Mar 2021-04-30